Market News & Trends
Study Finds EMD Millipore's Strat-M Synthetic Membrane Study Results
EMD Millipore, recently announced publication of a study showing that its Strat-M synthetic membrane predicts skin permeation of chemical compounds during in vitro transdermal diffusion…
PlasmaTech Biopharmaceuticals Announces Major Acquisition
PlasmaTech Biopharmaceuticals, Inc. recently announced it has entered into a definitive agreement to acquire Abeona Therapeutics, a company engaged in the development and commercialization of…
Capsugel Extends Inhaled Biotherapeutics Delivery Capability
Capsugel recently announced it has manufactured Phase II clinical trial supplies for a dry powder inhalation (DPI) formulation that efficiently delivers biotherapeutics to the lung.…
N-of-One Signs Business partner Agreement With Affymetrix
N-of-One, Inc. recently announced it has signed a business partner agreement with Affymetrix,a leading provider of DNA microarrays. Under this agreement, N-of-One will provide copy…
Vcaps® Plus Capsules: A New HPMC Capsule for Optimum Formulation of Pharmaceutical Dosage Forms
abstract Hypromellose (HPMC) capsules were originally formulated with a secondary gelling agent. This agent can delay dissolution in some circumstances and lead to unwanted issues…
Acquisition Acquisition Creates Most Robust Rare Disease Pipeline in Biotech
Alexion Pharmaceuticals, Inc. and Synageva BioPharma Corp. recently announced they have entered into a definitive agreement pursuant to which Alexion will acquire Synageva for consideration…
Xcelience CEO & President Named Finalist in Entrepreneur of The Year 2015 Awards
Xcelience's Derek Hennecke has been named a finalist in the EY Entrepreneur Of The Year 2015 Florida Awards. Mr. Hennecke was selected from more than…
Recombinant & Prophylactic Treatments Boost Global Haemophilia Therapeutics Market
Increased uptake of recombinant therapies and prophylactic use, coupled with improved diagnosis of haemophilia, is expected to drive the associated therapeutics market. Recombinant therapies are…
Alzheimer's Disease Treatment Market Value Will Exceed $13 Billion
The global market for Alzheimer’s Disease (AD) treatment will more than double in value from $4.9 billion in 2013 to reach an estimated $13.3 billion…
EMD Millipore Introduces Kits for the Analysis of Chromatin-Associated RNAs
EMD Millipore recently introduced Magna ChIRP RNA Interactome Kits, which allow researchers to more easily identify, recover, and analyze regions of chromatin that interact with…
Vetter Serializes the First Product for South Korea
Vetter recently announced the manufacture of the first commercial batches with single-use identification numbers. Following the introduction of a comprehensive serialization service last year, the…
Exco InTouch Predicts Substantial Growth in Device Integration
Exco InTouch predicts a substantial increase in device integration in clinical trials and real-world programs in 2015 and beyond. Device integration has proved highly beneficial,…
Innate Pharma and AstraZeneca Announce Global Agreement
Innate Pharma SA recently announced that it has signed a co-development and commercialization agreement with AstraZeneca, along with MedImmune, its global biologics research and development…
Clover Oncology Receives Breakthrough Therapy Designation
Clovis Oncology, Inc. recently announced the US FDA has granted Breakthrough Therapy designation for the company’s investigational agent rucaparib as monotherapy treatment of advanced ovarian…
Celgene to Acquire Biotech Company
Celgene Corporation and Quanticel Pharmaceuticals, Inc. recently announced a definitive share purchase agreement under which Celgene Corporation will acquire Quanticel. Through the agreement, Celgene will…
CMOCRO: Intuitive Platform Provides Quick Access to Global Database of Pharmaceutical Suppliers, Supports Partnering Decisions
By: Ashish Shukla, PhD CMOCRO is an intuitive platform designed to quickly access a global database of pharmaceutical suppliers, and aims to support…
Generex Announces New $11-Million Collaboration
Generex Biotechnology Corporation recently announced that it has entered into a non-binding Letter of Intent (LOI) to license the Generex proprietary RapidMis drug delivery technologies…
Investigational Brain Cancer Vaccine Produces Strong Immunological Response
A first-of-its kind cancer vaccine, SurVaxM, has demonstrated safety and tolerability in patients with recurrent or progressive malignant brain tumors, according to results of a…
Dicerna Presents New Data From Multiple Tumor Models
Dicerna Pharmaceuticals, Inc. recently announced promising new in vivo data for CTNNB1 DsiRNA in multiple patient-derived xenograft (PDX) and other models of diverse tumor types.…
Huntingdon Life Sciences & Harlan Laboratories Announce Significant Launch
Huntingdon Life Sciences and Harlan Laboratories recently announced the launch of the SHrN – the world’s first hairless NOD.SCID mouse model to reach the market.…
